These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30971377)

  • 1. Is the Evidence Provided by the SPRINT Trial Solid Enough to Support a Systolic Blood Pressure Threshold of 120 mmHg?
    García-Zamora S; Botto F
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):520-521. PubMed ID: 30971377
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPRINT Revisited: Updated Results and Implications.
    Wright JT; Whelton PK; Johnson KC; Snyder JK; Reboussin DM; Cushman WC; Williamson JD; Pajewski NM; Cheung AK; Lewis CE; Oparil S; Rocco MV; Beddhu S; Fine LJ; Cutler JA; Ambrosius WT; Rahman M; Still CH; Chen Z; Tatsuoka C;
    Hypertension; 2021 Dec; 78(6):1701-1710. PubMed ID: 34757768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPRINT, or False Start, Toward a Lower Universal Treated Blood Pressure Target in Hypertension.
    Esler M
    Hypertension; 2016 Feb; 67(2):266-7. PubMed ID: 26553232
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study.
    Okin PM; Kjeldsen SE; Devereux RB
    J Hypertens; 2018 Apr; 36(4):916-923. PubMed ID: 29176391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPRINT Trial Results: Latest News in Hypertension Management.
    Cushman WC; Whelton PK; Fine LJ; Wright JT; Reboussin DM; Johnson KC; Oparil S;
    Hypertension; 2016 Feb; 67(2):263-5. PubMed ID: 26553234
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Bulpitt CJ; Clement D; de Leeuw PW; Jääskivi M; Mancia G; O'Brien E; Palatini P; Tuomilehto J; Webster J;
    J Hypertens; 2004 Jan; 22(1):81-7. PubMed ID: 15106798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension Across the Atlantic: A Sprint or a Marathon?
    Volpe M; Citoni B; Coluccia R; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):99-102. PubMed ID: 28451910
    [No Abstract]   [Full Text] [Related]  

  • 12. Interpreting SPRINT: How low should you go?
    Thomas G; Nally JV; Pohl MA
    Cleve Clin J Med; 2016 Mar; 83(3):187-95. PubMed ID: 26974989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials.
    Heimark S; Mariampillai JE; Narkiewicz K; Nilsson PM; Kjeldsen SE
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):151-158. PubMed ID: 29663195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPRINT trial: It's not just the blood pressure!
    Berkelmans GF; Visseren FL; Jaspers NE; Spiering W; van der Graaf Y; Dorresteijn JA
    Eur J Prev Cardiol; 2017 Sep; 24(14):1482-1484. PubMed ID: 28749177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg.
    Kjeldsen SE; Oparil S; Narkiewicz K; Hedner T
    Blood Press; 2016; 25(1):1-3. PubMed ID: 26462684
    [No Abstract]   [Full Text] [Related]  

  • 19. Incremental effects of antihypertensive drugs: instrumental variable analysis.
    Markovitz AA; Mack JA; Nallamothu BK; Ayanian JZ; Ryan AM
    BMJ; 2017 Dec; 359():j5542. PubMed ID: 29273586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m-Power Heart Project - a nurse care coordinator led, mHealth enabled intervention to improve the management of hypertension in India: study protocol for a cluster randomized trial.
    Srinivasapura Venkateshmurthy N; Ajay VS; Mohan S; Jindal D; Anand S; Kondal D; Tandon N; Rao MB; Prabhakaran D
    Trials; 2018 Aug; 19(1):429. PubMed ID: 30086778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.